Abstract:Background It is known that amyloid-β peptide (Aβ) plays a pivotal role in the pathogenesis of Alzheimer's disease (AD). Interaction between Aβ and the receptor for advanced glycation end products (RAGE) has been implicated in neuronal degeneration associated with this disease. Pinocembrin, a flavonoid abundant in propolis, has been reported to possess numerous biological activities beneficial to health. Our previous studies have demonstrated that pinocembrin has neuroprotective effects on ischemic and vascular dementia in animal models. It has been approved by the State Food and Drug Administration of China for clinical use in stroke patients. Against this background, we investigated the effects of pinocembrin on cognitive function and neuronal protection against Aβ-induced toxicity and explored its potential mechanism. Methods Mice received an intracerebroventricular fusion of Aβ 25-35 . Pinocembrin was administrated orally at 20 mg/kg/day and 40 mg/kg/day for 8 days. Behavioral performance, cerebral cortex neuropil ultrastructure, neuronal degeneration and RAGE expression were assessed. Further, a RAGE-overexpressing cell model and an AD cell model were used for investigating the mechanisms of pinocembrin. The mechanisms underlying the efficacy of pinocembrin were conducted on target action, mitochondrial function and potential signal transduction using fluorescence-based multiparametric technologies on a high-content analysis platform. Results Our results showed that oral administration of pinocembrin improved cognitive function, preserved the ultrastructural neuropil and decreased neurodegeneration of the cerebral cortex in Aβ 25-35 -treated mice. Pinocembrin did not have a significant effect on inhibiting Aβ 1-42 production and scavenging intracellular reactive oxygen species (ROS). However, pinocembrin significantly inhibited the upregulation of RAGE transcripts and protein expression both in vivo and in vitro , and also markedly depressed the activation of p38 mitogen-activated protein kinase (MAPK)-MAPKAP kinase-2 (MK2)-heat shock protein 27 (HSP27) and stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK)-c-Jun pathways and the downstream nuclear factor κB (NFκB) inflammatory response subsequent to Aβ-RAGE interaction. In addition, pinocembrin significantly alleviated mitochondrial dysfunction through improving mitochondrial membrane potential and inhibiting mitochondrial oxidative stress, and regulated mitochondrion-mediated apoptosis by restoration of B cell lymphoma 2 (Bcl-2) and cytochrome c and inactivation of caspase 3 and caspase 9. Conclusions Pinocembrin was shown to infer cognitive improvement and neuronal protection in AD models. The mechanisms of action of the compound were illustrated on RAGE-dependent transduction inhibition and mitochondrion protection. It appears to be a promising candidate for the prevention and therapy of AD.

CART Peptide Activates the Nrf2/HO-1 Antioxidant Pathway and Protects Hippocampal Neurons in a Rat Model of Alzheimer's Disease

CART Mitigates Oxidative Stress and DNA Damage in Memory Deficits of APP/PS1 Mice Via Upregulating Β‑amyloid Metabolism‑associated Enzymes

CART Modulates Beta-Amyloid Metabolism-Associated Enzymes and Attenuates Memory Deficits in APP/PS1 Mice

Cart Treatment Improves Memory and Synaptic Structure in App/Ps1 Mice

Ganoderma Lucidum Triterpenoids (glts) Reduce Neuronal Apoptosis Via Inhibition of ROCK Signal Pathway in APP/PS1 Transgenic Alzheimer's Disease Mice

CART Protects Brain from Damage Through ERK Activation in Ischemic Stroke

Cocaine- and Amphetamine-Regulated Transcript Peptide Increases Mitochondrial Respiratory Chain Complex Ii Activity and Protects Against Oxygen-Glucose Deprivation in Neurons

Cocaine-and Amphetamine-Regulated Transcript Modulates Peripheral Immunity and Protects Against Brain Injury in Experimental Stroke

Cocaine- and Amphetamine-Regulated Transcript Protects Synaptic Structures in Neurons after Ischemic Cerebral Injury.

Protective Effect of Cocaine-and Amphetamine-Regulated Transcript Peptide in Ischemic Brain Injury

Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells.

Roles of Cocaine- and Amphetamine-Regulated Transcript in the Central Nervous System

A cocaine-regulated and amphetamine-regulated transcript inhibits oxidative stress in neurons deprived of oxygen and glucose.

Neuroprotective mechanisms of cocaine-and amphetamine-regulated transcript peptides in brain ischemia

Daphnetin protects neurons in an Alzheimer disease mouse model and normal rat neurons by inhibiting BACE1 activity and activating the Nrf2/HO-1 pathway

Icariin Inhibits Neurotoxicity of Beta-Amyloid by Upregulating Cocaine-Regulated and Amphetamine-Regulated Transcripts

The role of CART peptide in learning and memory: A potential therapeutic target in memory-related disorders

Effect of cocaine-amphetamine-regulated transcript peptide on the content of 4-hydroxy-2-noneral and infarct volume after cerebral ischenia/reperfusion in mice

Pinocembrin Protects Against Β-Amyloid-induced Toxicity in Neurons Through Inhibiting Receptor for Advanced Glycation End Products (Rage)-Independent Signaling Pathways and Regulating Mitochondrion-Mediated Apoptosis.

Effect of cocaine-and amphetamine-regulated transcription peptide on synaptic formation in cultured cortical neurons subjected to oxygen-glucose deprivation

Neuroprotective Mechanislr of Cocaine-and Mnphetane-Wgulated Transcript Peptides in Brain Ischemia